HIND - ReShape Lifesciences Inc.
2.8
-0.110 -3.929%
Share volume: 31,345
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.91
-0.11
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 05-20-2025 | 08-14-2025 | 11-14-2025 | |
| Total revenue | 1.944 M | 1.965 M | 2.292 M | 1.113 M | 1.242 M | 34.627 K | |
| Cost of revenue | 779.000 K | 831.000 K | 853.000 K | 432.000 K | 643.000 K | 16.577 K | |
| Gross profit | 1.165 M | 1.134 M | 1.439 M | 681.000 K | 599.000 K | 18.050 K | |
| -2.66% | 26.90% | -52.68% | -12.04% | -96.99% | |||
| Operating expenses | 3.375 M | 3.188 M | 3.200 M | 1.991 M | 2.067 M | 884.021 K | |
| Selling general and admin | 2.891 M | 2.789 M | 2.801 M | 1.627 M | 1.591 M | 844.344 K | |
| Research and development | 484.000 K | 399.000 K | 399.000 K | 364.000 K | 476.000 K | 39.677 K | |
| Total expenses | 3.375 M | 3.188 M | 3.200 M | 2.887 M | 3.361 M | 8.592 M | |
| -5.54% | 0.38% | -9.78% | 16.42% | 155.65% | |||
| Operating income | -2.210 M | -2.054 M | -1.761 M | -2.206 M | -2.762 M | -8.574 M | |
| Ebit | -2.188 M | -2.013 M | -1.575 M | 1.497 M | -2.640 M | -8.570 M | |
| Pretax income | -2.179 M | -1.580 M | -1.575 M | 1.481 M | -2.622 M | -8.595 M | |
| -27.49% | -0.32% | -194.03% | -277.04% | 227.81% | |||
| Income tax | 14.000 K | 15.000 K | 6.000 K | 7.000 K | 8.000 K | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.193 M | -1.595 M | -1.581 M | 1.474 M | -2.630 M | -8.595 M | |
| 27.27% | 0.88% | 193.23% | -278.43% | -226.82% |